Heterogeneity of ductal carcinoma in situ and its effects on management (Q36583072)

15 August 2017

1 reference

title

Heterogeneity of ductal carcinoma in situ and its effects on management (English)

1 reference

15 August 2017

1 reference

Kefah Mokbel

1

1 reference

PubMed ID

16945771

15 August 2017

Bruno Cutuli

series ordinal

2

1 reference

15 August 2017

1 September 2006

1 reference

Lancet Oncology Commission

15 August 2017

1 reference

15 August 2017

7

1 reference

15 August 2017

756-765

1 reference

15 August 2017

9

1 reference

Findings from 752,081 clinical breast examinations reported to a national screening program from 1995 through 1998

15 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970861-0

7 January 2021

Mammography of ductal carcinoma in situ of the breast: review of 909 cases with radiographic-pathologic correlations

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970861-0

7 January 2021

Increases in ductal carcinoma in situ (DCIS) of the breast in relation to mammography: a dilemma.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970861-0

7 January 2021

Diagnostic performance of digital versus film mammography for breast-cancer screening

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970861-0

7 January 2021

Screening women at increased risk with MRI

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970861-0

7 January 2021

Determination of the presence and extent of pure ductal carcinoma in situ by mammography and magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970861-0

7 January 2021

Mammary ductoscopy: current status and future prospects

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970861-0

7 January 2021

Consistency in the observation of features used to classify duct carcinoma in situ (DCIS) of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970861-0

7 January 2021

Prediction of local recurrence of ductal carcinoma in situ of the breast using five histological classifications: A comparative study with long follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970861-0

7 January 2021

Reproducibility of new classification schemes for the pathology of ductal carcinoma in situ of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970861-0

7 January 2021

A critical appraisal of six modern classifications of ductal carcinoma in situ of the breast (DCIS): correlation with grade of associated invasive carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970861-0

7 January 2021

The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970861-0

7 January 2021

Ductal carcinoma in situ, complexities and challenges.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970861-0

7 January 2021

Characteristics associated with recurrence among women with ductal carcinoma in situ treated by lumpectomy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970861-0

7 January 2021

Prognostic classification of breast ductal carcinoma-in-situ

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970861-0

7 January 2021

Ductal carcinoma in situ. The success of breast conservation therapy: a shared experience of two single institutional nonrandomized prospective studies

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970861-0

7 January 2021

Are cellular polarisation and mitotic frequency prognostic factors for local recurrence in patients with ductal carcinoma in situ of the breast?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970861-0

7 January 2021

A prognostic index for ductal carcinoma in situ of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970861-0

7 January 2021

Oestrogen receptor negativity as a marker for high‐grade ductal carcinoma in situ of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970861-0

7 January 2021

Biological markers that predict clinical recurrence in ductal carcinoma in situ of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970861-0

7 January 2021

Comparative genomic hybridization of ductal carcinoma in situ of the breast-evidence of multiple genetic pathways

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970861-0

7 January 2021

Extensive ductal carcinoma In situ with small foci of invasive ductal carcinoma: evidence of genetic resemblance by CGH.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970861-0

7 January 2021

Standard for the management of ductal carcinoma in situ of the breast (DCIS).

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970861-0

7 January 2021

Predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970861-0

7 January 2021

Trends in the treatment of ductal carcinoma in situ of the breast.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970861-0

7 January 2021

Surgery and outcomes of ductal carcinoma in situ of the breast: a population-based study in Australia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970861-0

7 January 2021

Mortality among women with ductal carcinoma in situ of the breast in the population-based surveillance, epidemiology and end results program

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970861-0

7 January 2021

Skin-sparing mastectomy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970861-0

7 January 2021

Local control in ductal carcinoma in situ treated by excision alone: incremental benefit of larger margins

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970861-0

7 January 2021

Ipsilateral local recurrence in relation to therapy and morphological characteristics in patients with ductal carcinoma in situ of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970861-0

7 January 2021

Analysis of 676 cases of ductal carcinoma in situ of the breast from 1971 to 1995: diagnosis and treatment--the experience of one institute

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970861-0

7 January 2021

Breast-conserving therapy for ductal carcinoma in situ of the breast: the French Cancer Centers' experience

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970861-0

7 January 2021

Carcinoma in situ of the female breast. 10 year follow-up results of a prospective nationwide study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970861-0

7 January 2021

Prospective study of wide excision alone for ductal carcinoma in situ of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970861-0

7 January 2021

The University of Southern California/Van Nuys prognostic index for ductal carcinoma in situ of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970861-0

7 January 2021

Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the National Surgical Adjuvant Breast and Bowel Project experience

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970861-0

7 January 2021

Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970861-0

7 January 2021

Breast-conserving treatment with or without radiotherapy in ductal carcinoma-in-situ: ten-year results of European Organisation for Research and Treatment of Cancer randomized phase III trial 10853--a study by the EORTC Breast Cancer Cooperative Gro

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970861-0

7 January 2021

Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970861-0

7 January 2021

SweDCIS: Radiotherapy after sector resection for ductal carcinoma in situ of the breast. Results of a randomised trial in a population offered mammography screening

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970861-0

7 January 2021

Effects of patient selection on the applicability of results from a randomised clinical trial (EORTC 10853) investigating breast-conserving therapy for DCIS.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970861-0

7 January 2021

Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970861-0

7 January 2021

Sentinel lymph node biopsy for localised ductal carcinoma in situ?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970861-0

7 January 2021

Outcome after invasive local recurrence in patients with ductal carcinoma in situ of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970861-0

7 January 2021

Salvage treatment for local or local-regional recurrence after initial breast conservation treatment with radiation for ductal carcinoma in situ

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970861-0

7 January 2021

The frequency of ipsilateral second tumors after breast-conserving surgery for DCIS: a population based analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970861-0

7 January 2021

Age at diagnosis and outcome for women with ductal carcinoma-in-situ of the breast: a critical review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970861-0

7 January 2021

Mammographically detected ductal carcinoma in situ of the breast treated with breast-conserving surgery and definitive breast irradiation: long-term outcome and prognostic significance of patient age and margin status

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970861-0

7 January 2021

Long-term outcome after breast-conservation treatment with radiation for mammographically detected ductal carcinoma in situ of the breast

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970861-0

7 January 2021

Consensus Conference on the Treatment of In Situ Ductal Carcinoma of the Breast, April 22-25, 1999.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970861-0

7 January 2021

Histological margin assessment for breast ductal carcinoma in situ: precision and implications.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970861-0

7 January 2021

Relationship between excision volume, margin status, and tumor size with the development of local recurrence in patients with ductal carcinoma-in-situ treated with breast-conserving therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970861-0

7 January 2021

The value of breast lumpectomy margin assessment as a predictor of residual tumor burden in ductal carcinoma in situ of the breast.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970861-0

7 January 2021

Predictors of positive margins after local excision of ductal carcinoma in situ

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970861-0

7 January 2021

Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970861-0

7 January 2021

Ductal carcinoma in situ of the male breast. Analysis of 31 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970861-0

7 January 2021

Ductal carcinoma in situ (DCIS) in the male breast: a morphologic study of 84 cases of pure DCIS and 30 cases of DCIS associated with invasive carcinoma--a preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970861-0

7 January 2021

Breast cancer occurred after treatment for Hodgkin's disease: analysis of 133 cases

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970861-0

7 January 2021

Management of breast cancer after Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970861-0

7 January 2021

Breast cancer in patients irradiated for Hodgkin's disease: a clinical and pathologic analysis of 45 events in 37 patients

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970861-0

7 January 2021

An adequate margin of excision in ductal carcinoma in situ

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970861-0

7 January 2021

Is excision alone adequate treatment for low-risk ductal carcinoma-in-situ of the breast?

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2806%2970861-0

7 January 2021

10.1016/S1470-2045(06)70861-0

Identifiers

DOI

1 reference

15 August 2017

1 reference

PubMed ID

16945771